 |
 |
|
Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to an ongoing Phase IIIb study in malignant mesothelioma, Alfacell is conducting a Phase I/II trial of ONCONASE in non-small cell lung cancer (NSCLC) and other solid tumors.
|
|
| Recent News |
|
|
August 1st, 2008
|
|
Alfacell Receives NASDAQ Delisting Letter
|
|
|
July 21st, 2008
|
|
Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
|
|
|
July 18th, 2008
|
|
Alfacell Receives NASDAQ Non-Compliance Notification
|
|
|
July 15th, 2008
|
|
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
|
|
|
June 26th, 2008
|
|
Alfacell Receives NASDAQ Non-Compliance Notification
|
|
|
Press Release Archive
|
|
All Archived Press Releases are now easily available for viewing
|
|
| Upcoming Events |
|
Third Quarter 2008 Results Conference Call 06-09-08
ONCONASE Phase IIIb Clinical Trial Prelim. Data Update 05-29-08
Second Quarter 2008 Results Conference Call and Webcast 03-07-08
First Quarter 2008 Results Conference Call and Webcast 12-10-07
Webcast of RNA Interference-Like Mechanics of RNase Therapeutics 11-29-07
Webcast of Alfacell at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 11-05-07
Webcast of Alfacell Fiscal Year End and Fourth Quarter 2007 Results Conference Call 10-15-07
Webcast of Alfacell at Biotechnology Industry Organization Investor Forum 10-11-07
Webcast of Alfacell Corporation Presentation at the UBS 2007 Global Life Sciences Conference 9-26-07
Webcast of Alfacell Corporation Presentation at the Noble Financial Two Double-O-Seven Conference 8-20-07
Webcast of Alfacell Corporation Presentation at the C.E. Unterberg Towbin Emerging Growth Opportunities Conference 7-12-2007
|
|
|
| Information Center |
|
|
Corporate Presentation: March 2008
|
|
|
|
|
2006 Shareholder Letter
|
|
|
|
|
Company Fact Sheet: August 2007
|
|
|
|
|
View animated model of the ONCONASE Mechanism in Action!
|
|
|
|
|
Dr. Harvey Pass, Alfacell Thoracic Cancer Advisory Board Member, on the CBS Evening News, October 25, 2006
|
|
|
|
|
Message from Tommy G. Thompson, former U.S. Secretary, Health and Human Services
|
|
|
|
|
Audit Committee Charter
|
|
|
|
|
Compensation Committee Charter
|
|
|
|
|
Corporate Governance and Nominating Committee Charter
|
|
|
|
|
1998-2008, Alfacell Corporation
300 Atrium Drive, Somerset, NJ 08873
Phone: 732-652-4525 Fax: 732-652-4575
Please read our Disclaimer
|
|
Home
Contact us
|
|